Technical Analysis for MBRX - Moleculin Biotech, Inc.

Grade Last Price % Change Price Change
grade F 1.12 -3.45% -0.04
MBRX closed down 3.45 percent on Friday, September 20, 2019, on 1.46 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MBRX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
200 DMA Resistance Bearish -3.45%
Bearish Engulfing Bearish -5.08%
Fell Below 200 DMA Bearish -5.08%
Stochastic Sell Signal Bearish -5.08%
Upper Bollinger Band Walk Strength -5.08%
Overbought Stochastic Strength -5.08%
Upper Bollinger Band Touch Strength -5.08%

Older signals for MBRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company also develops other drugs, including WP1066 Portfolio, a portfolio of small molecules targeting the modulation of transcription factors involved in cancer; and WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer and glioblastoma. Moleculin Biotech, Inc. was founded in 2015 and is headquartered in Houston, Texas.
Medicine Cancer Pharmaceutical Oncology Chemotherapy Acute Myeloid Leukemia Antineoplastic Drugs Glioblastoma Refractory Acute Myeloid Leukemia
Is MBRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.15
52 Week Low 0.7772
Average Volume 241,160
200-Day Moving Average 1.2241
50-Day Moving Average 1.1396
20-Day Moving Average 1.1466
10-Day Moving Average 1.177
Average True Range 0.0651
ADX 22.24
+DI 17.0231
-DI 11.3305
Chandelier Exit (Long, 3 ATRs ) 1.0947
Chandelier Exit (Short, 3 ATRs ) 1.2653
Upper Bollinger Band 1.2345
Lower Bollinger Band 1.0587
Percent B (%b) 0.35
BandWidth 15.332287
MACD Line 0.013
MACD Signal Line 0.0123
MACD Histogram 0.0007
Fundamentals Value
Market Cap 22.69 Million
Num Shares 20.3 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -2.38
Price-to-Sales 0.00
Price-to-Book 1.59
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.23
Resistance 3 (R3) 1.24 1.21 1.21
Resistance 2 (R2) 1.21 1.19 1.21 1.20
Resistance 1 (R1) 1.17 1.17 1.16 1.16 1.20
Pivot Point 1.14 1.14 1.14 1.14 1.14
Support 1 (S1) 1.10 1.12 1.09 1.09 1.04
Support 2 (S2) 1.07 1.10 1.07 1.04
Support 3 (S3) 1.03 1.07 1.03
Support 4 (S4) 1.02